Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605 / JART ‐1501 study

Author:

Fukuda Minoru1ORCID,Yamaguchi Masafumi2,Yamazaki Takuya3,Funaki Soichiro4,Mukae Hiroshi5,Fukuoka Junya6,Nabeshima Kazuki7,Tateyama Hisashi8,Ashizawa Kazuto9,Tomiyama Noriyuki10,Hara Masaki11,Seto Takashi2ORCID,Okumura Meinoshin1213,Sugio Kenji1415ORCID

Affiliation:

1. Cancer Treatment Center Nagasaki Prefecture Shimabara Hospital Shimabara Japan

2. Department of Thoracic Oncology National Hospital Organization Kyusyu Cancer Center Fukuoka Japan

3. Department of Radiology Nagasaki University Hospital Nagasaki Japan

4. Department of General Thoracic Surgery Osaka University Graduate School of Medicine Suita Osaka Japan

5. Department of Respiratory Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

6. Department of Pathology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

7. Department of Pathology, Faculty of Medicine Fukuoka University Fukuoka Japan

8. Department of Pathology Kasugai Municipal Hospital Kasugai Japan

9. Department of Clinical Oncology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

10. Department of Radiology Osaka University Graduate School of Medicine Osaka Japan

11. Department of Radiology Nagoya City University West Medical Center Nagoya Japan

12. Osaka Toneyama Medical Center Osaka Japan

13. Japanese Association for Research on the Thymus (JART) Osaka Japan

14. Department of Thoracic and Breast Surgery Oita University Faculty of Medicine Oita Japan

15. Lung Oncology Group in Kyusyu (LOGiK) Fukuoka Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Reference31 articles.

1. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?;Marx A;J Thorac Oncol,2021

2. Squamous cell carcinoma of the thymus. An analysis of eight cases

3. Foundation for Promotion of Cancer Research.Cancer statistics in Japan2021

4. Multimodal management of stages III–IVa malignant thymoma

5. Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3